BETA logo

BETA Drugs Limited

BETA·NSE·
2,090.20 -116.60 (-5.28%)
Market Cap2099.67 Cr
PE Ratio51.08
Volume23,179
Day High - Low2208.50 - 2076.00
52W High-Low2807.90 - 990.10
DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
18.80%
Strong
P/E
51.08x
Expensive
Debt / Equity
0.60
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day2076
2209
52W990.10
2808
DocStoX take

Supported by growth (9.7) and risk (8.4), but held back by valuation (0.0). Growth looks strong at 9.7, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Solid
ROE 18.8%
Valuation
Expensive
P/E 51.1×
Growth
Strong
Revenue +27.1% 5Y CAGR
Risk
Low risk
D/E 0.60
Momentum
Firm
61% of 52-week range

At a glance

Market Cap
₹2,100 Cr
52W High / Low
₹2808 / ₹990
Dividend Yield
0.00%
Promoter Holding
59.10%
EPS (TTM)
₹40.92
Book Value
₹241.00

Key highlights

  • Profitable in all of the last 5 years
  • Profit compounding 28% a year
  • Revenue compounding 27% a year
  • Valuation is weak (0.0/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

BETA DRUGS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.